SULFASALAZINE |
NSC-667219 |
SALAZOPYRIN-EN |
SALAZOSULFAPYRIDINE |
AZULFIDINE EN |
AZULFIDINE EN-TABS |
SAS-500 |
COLIZINE |
SALAZOPYRIN |
S.A.S. |
SULPHASALAZINE |
UCINE |
AZULFIDINE |
S.A.S.-500 |
SALAZOPYRIN E.C. |
NSC-203730 |
SALICYLAZOSULFAPYRIDINE |
SALAZOSULFAPYRIDINUM |
SULFASALAZINA |
SALAZOPYRIN® |
2-HYDROXY-5-[4-(PYRIDIN-2-YLSULFAMOYL)-PHENYLAZO]-BENZOIC ACID |
AZULFIDINE® |
5-(P-(2-PYRIDYLSULFAMYL)PHENYLAZO)SALICYLIC ACID |
SULFASALAZINUM |
AZOPYRIN |
SULFASALAZIN |
4-(PYRIDYL-2-AMIDOSULFONYL)-3'-CARBOXY-4'-HYDROXYAZOBENZENE |
5-(4-(2-PYRIDYLSULFAMOYL)PHENYLAZO)-2-HYDROXYBENZOIC ACID |
2-HYDROXY-5-((4-((2-PYRIDINYLAMINO)SULFONYL)PHENYL)AZO)BENZOIC ACID |
SALAZOSULFAPIRIDINA |
5-((P-(2-PYRIDYLSULFAMOYL)PHENYL)AZO)SALICYLIC ACID |
SALAZOPYRIDIN® |
rxcui:9524 |
pubchem.compound:5353980 |
chemidplus:599-79-1 |
chembl:CHEMBL421 |
drugbank:00795 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antiinflammatory agent,DMARD |
Drug Class | antirheumatic agents |
Year of Approval | 1950 |
Drug Class | anti-inflammatory agents, non-steroidal |
Drug Categories | agents causing hyperkalemia |
Drug Categories | agents that produce hypertension |
Drug Categories | aminosalicylate |
Drug Categories | anti-inflammatory agents, non-steroidal (non-selective) |
Drug Categories | genito urinary system and sex hormones |
Drug Categories | gynecological antiinfectives and antiseptics |
Drug Categories | immunosuppressive agents |
Drug Categories | methemoglobinemia associated agents |
Drug Categories | nephrotoxic agents |
Drug Categories | non cox-2 selective nsaids |
Drug Categories | oatp1b1/slco1b1 inhibitors |
Drug Categories | oatp1b3 inhibitors |
Drug Categories | salicylates |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Arachidonate 5-lipoxygenase inhibitor |
inhibitor (inhibitory) |
Trial Name | sulfasalazine,Azulfidine, Salazopyrin |
Novel drug target | Established target |
Mechanism of Interaction | Cyclooxygenase inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Cyclooxygenase inhibitor |
Novel drug target | Established target |
SULFASALAZINE | DrugBank Drug Name |
599-79-1 | CAS Number |
Apo Sulfasalazine Tab 500mg | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | agents causing hyperkalemia |
SULFASALAZINE | Primary Drug Name |
Drug Class | anti-inflammatory agents, non-steroidal |
Year of Approval | 1950 |
Drug Class | antirheumatic agents |
Drug Indications | antiinflammatory agent,DMARD |
Drug Class | Small Molecule |
FDA Approval | approved |
C29469 | NCI drug code |
CHEMBL421 | ChEMBL Drug ID |
D02ZTJ | TTD Drug ID |
SULFASALAZINE | GuideToPharmacology Ligand Name |